Cardiovascular risk assessment in idiopathic inflammatory myopathies: a multicentre international study by the myositis audit and research collaborative group
Over a third of patients with IIM are at moderate-high-risk of cardiovascular events in 10 years. Steroid use and dyslipidaemia were modifiable risk factors that were statistically significant predictors of risk. Despite this, there is a lack of adherence to current guidelines advising regular CVD risk assessment and use of statins for primary prevention in this moderate-high risk group.
Authors
- Ryan Moore
- Tammy Luk
- Samuel Katsuyuki Shinjo (ORCID: https://orcid.org/0000-0002-3682-4517)
- Anamika Kumari Anuja (ORCID: https://orcid.org/0000-0003-0722-8756)
- Aman Kumar (ORCID: https://orcid.org/0000-0002-4804-5182)
- Marco Fornaro (ORCID: https://orcid.org/0000-0003-1716-7432)
- Tolulope A. Agunbiade
- Y. K. Tang
- Jessica Day (ORCID: https://orcid.org/0000-0001-8528-4361)
- Ho So (ORCID: https://orcid.org/0000-0001-7113-9390)
- Vidya Sadanand Limaye
- Lekshmi Minikumari Rahulan (ORCID: https://orcid.org/0009-0003-5921-3684)
- Athena Chin (ORCID: https://orcid.org/0009-0000-2423-7836)
- Devansh Lalwani
- Vikas Agarwal
Institutions
- Royal Adelaide Hospital (AU)
- The Royal Melbourne Hospital (AU)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Chinese University of Hong Kong (HK)
- Universidade de São Paulo (BR)
- King Edward Memorial Hospital and Seth G.S. Medical College (IN)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Kwong Wah Hospital (CN)
- Flinders Medical Centre (AU)
- The Royal Wolverhampton NHS Trust (GB)
- University of Bari Aldo Moro (IT)
- University of Hong Kong (HK)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1016/j.semarthrit.2025.152898
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00